Antibacterial agents in clinical development

Sequella Acquires Exclusive Worldwide Rights to Pfizer’s ...

FOR IMMEDIATE RELEASE: July 17, 2013 Sequella Acquires Exclusive Worldwide Rights to Pfizer’s Sutezolid, Currently in Clinical Development for Tuberculosis Sequella Obtains Development and Commercialization Rights to Sutezolid for All Indications

  Development, Clinical, Rights, Acquire, Worldwide, Exclusive, Currently, Sequella acquires exclusive worldwide rights, Sequella, Sutezolid, Currently in clinical development

Natural products to drugs: natural product derived ...

Table 1 NP-derived drugs launched in the United States, Europe or Japan since 1998 by year with reference to their lead compound, classification and therapeutic area Year Generic name (trade name) Lead compound Classification Disease area References 1998 orlistat (XenicalR) lipstatin semi-synthetic NPa antiobesity 35–39 1998 cefoselis (WincefR) cephalosporin NP-deriveda antibacterial …

  Product, Drug, Antibacterial, Natural, Natural products, Products to drugs

continuous antibiotic infusions - SurgicalCriticalCare.net

4 Approved 5/15/07 REFERENCES 1. Grant EM, Kuti JL, Nicolau DP, et al. Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital.

  Antibiotic, Clinical, Continuous, Infusion, Continuous antibiotic infusions

Macrobid (nitrofurantoin monohydrate/macrocrystals) …

This ART is to show size, copy placement and color breaks. Actual colors will be matched on press to approved color standards and/or PMS color swatches.

  Nitrofurantoin

Scientific guidelines with SmPC recommendations

Scientific guidelines with SmPC recommendations EMA/813125/2012 Page 3/5 . Guidelines Reference to specific SmPC section(s) Evaluation of the pharmacokinetics of medicinal products in

Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5

Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2015, 7(2):872-875 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5

  Research, Article, Issn, 0975 7384 coden, 0975, 7384, Coden, Research article issn

HIGHLIGHTS OF PRESCRIBING INFORMATION WARNINGS …

2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Acute Bacterial Skin and Skin Structure Infections ORBACTIV® (oritavancin) for injection is indicated for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by …

  Information, Prescribing, Full, Prescribing information, Full prescribing information

PRODUCT MONOGRAPH - Paladin Labs Inc.

MONUROL (fosfomycin tromethamine), a phosphonic acid derivative is the mono-acid salt of fosfomycin with tromethamine.

  Monurol

HIGHLIGHTS OF PRESCRIBING INFORMATION See Full …

2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1. Complicated Urinary Tract Infections (cUTI), including Pyelonephritis VABOMERE™ is indicated for the treatment of patients 18 years of age and older with

  Information, Prescribing, Prescribing information